[1]
“Assessing the Financial Immunity: A Pre- and Post-COVID Comparative Analysis of Sustainable Growth in Indian Pharmaceuticals Companies”, IJMPR, vol. 5, no. 1, pp. 74–81, Mar. 2026, doi: 10.55829/engpv623.